Cited by 30Acute Ischemic Stroke ManagementNeuroinflammation and Neurodegeneration MechanismsNeurological Disorders and Treatments

Solulin reduces infarct volume and regulates gene-expression in transient middle cerebral artery occlusion in rats

Open access
Ryang, Yu-Mi, Dang, Jon, Kipp, Markus, Petersen, Karl-Uwe, Fahlenkamp, Astrid V, Gempt, Jens, Wesp, Dominik, Rossaint, Rolf +2 more·2011·BMC Neuroscience

Abstract

BACKGROUND: Thrombolysis after acute ischemic stroke has only proven to be beneficial in a subset of patients. The soluble recombinant analogue of human thrombomodulin, Solulin, was studied in an in vivo rat model of acute ischemic stroke. METHODS: Male SD rats were subjected to 2 hrs of transient middle cerebral artery occlusion (tMCAO). Rats treated with Solulin intravenously shortly before reperfusion were compared to rats receiving normal saline i.v. with respect to infarct volumes, neurological deficits and mortality. Gene expression of IL-6, IL-1β, TNF-α, MMP-9, CD11B and GFAP were semiquantitatively analyzed by rtPCR of the penumbra. RESULTS: 24 hrs after reperfusion, rats were neurologically tested, euthanized and infarct volumes determined. Solulin significantly reduced mean total (p=0.001), cortical (p=0.002), and basal ganglia (p=0.036) infarct volumes. Hippocampal infarct volumes (p=0.191) were not significantly affected. Solulin significantly downregulated the expression of IL-1β (79%; p<0.001), TNF-α (59%; p=0.001), IL-6 (47%; p=0.04), and CD11B (49%; p=0.001) in the infarcted cortex compared to controls. CONCLUSIONS: Solulin reduced mean total, cortical and basal ganglia infarct volumes and regulated a subset of cytokines and proteases after tMCAO suggesting the potency of this compound for therapeutic interventions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2202-12-113

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The tMCAO model reflects events that occur in ischaemic stroke in humans after treatment with thrombolytic agents.

    “This model reflects events that occur in ischaemic stroke in humans after treatment with thrombolytic agents [28,29].”

    From Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats (2020) · cites this paper as [29]

    The Methods (page unavailable) describe a rat tMCAO model in which blood flow was restored by removing the occluding thread. The Background (page unavailable) discusses thrombolytic treatment in human stroke, but the paper does not state that thread-removal reperfusion reflects events after thrombolysis in humans. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ryang, Y.-M., Dang, J., Kipp, M., Petersen, K.-U., Fahlenkamp, A. V., Gempt, J., Wesp, D., Rossaint, R., Beyer, C., & Coburn, M.
Affiliations
  • TUM Klinikum (DE)
  • RWTH Aachen University (DE)
  • Paion (Germany) (DE)
  • Universitätsklinikum Aachen (DE)
  • Universitätsmedizin Göttingen (DE)
Corresponding author
Ryang, Yu-Mi
Venue
BMC Neuroscience
Published
2011-11-14
Volume
12
Issue
1
Pages
113-113
ISSN
1471-2202 (ISSN-L)
OpenAlex
W1998528194
Cited by
30
References
40
Citations by year
2025: 1 · 2023: 1 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 6 · 2014: 3 · 2013: 3 · 2012: 3
FWCI
2.17
Type
journal article
Language
en
Open access
Locations
  • BMC Neuroscience (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • GRO (submittedVersion, cc-by)
  • RWTH Publications (RWTH Aachen) (submittedVersion, cc-by)
  • RWTH Publications (RWTH Aachen)
Funders
RWTH Aachen University
Topics
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
Keywords
thrombomodulin, acute ischemic stroke, transient middle cerebral artery occlusion, infarct size, neuroinflammation, cytokines, IL-1β, TNF-α, interleukin-6, CD11b, MMP-9, glial fibrillary acidic protein, penumbra, reperfusion, basal ganglia infarction, neuroprotection
MeSH terms
Animals, Ischemic Attack, Transient, Disease Models, Animal, Gene Expression Regulation, Male, Recombinant Proteins, Rats, Sprague-Dawley, Receptors, Thrombin, Neuroprotective Agents, Infarction, Middle Cerebral Artery, Brain Infarction, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review